FDA Approved: CYSVIEW — Supplemental Application (Photocure Inc.)

View source ↗

Summary

FDA approved a supplemental application for CYSVIEW to update its labeling (hexaminolevulinate hydrochloride) for use in the detection of bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Cysview (hexaminolevulinate hydrochloride)

Snippet

SUPPL AP for CYSVIEW (HEXAMINOLEVULINATE HYDROCHLORIDE)